Fig. 1.
Fig. 1. Competitive quantitative PCR values at 9 months on imatinib mesylate therapy by cytogenetic response. / Horizontal markings on graphs are median values.

Competitive quantitative PCR values at 9 months on imatinib mesylate therapy by cytogenetic response.

Horizontal markings on graphs are median values.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal